Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer.

Nicole C LoroñaLinda S CookMei-Tzu C TangDeirdre A HillCharles L WigginsChristopher I Li

Published in: Cancer causes & control : CCC (2021)

Our findings suggest that some antihypertensive medications may be associated with adverse breast cancer outcomes among women with certain molecular subtypes. Additional studies are needed to confirm these findings.

Keyphrases

blood pressure
hypertensive patients
cardiovascular events
risk factors
type diabetes
emergency department
cardiovascular disease
single molecule
young adults
risk assessment
adverse drug